Synthetic Biology & Health

The seminal achievements of constructing the first synthetic bacterial cell and first minimal cell are key to understanding fundamentals of biology. This work is also expanding the ability to produce various kinds of biologically-based products including new types of medicine and renewable fuels. As the team progresses on their science goals, they are equally focused on the societal implications of this work. Synthetic genomics holds great promise for the future, and our team is at the forefront of discoveries and important public dialogue.

Developing Genetic Tools to Manipulate African Swine Fever Virus and Generate Attenuated Strains

Show Project

No More Needles!

Transforming the Treatment of Type 1 Diabetes

Show Project Video

BREAD: Toward Development of a Vaccine for Contagious Bovine Pleuropneumonia (CBPP)

Show Project

Synthetic Genomics to Generate a Stable Epstein-Barr Virus Infectious Clone

Show Project

Viral Synthetic Genomics to Engineer Large dsDNA Viruses

Rapid engineering of large dsDNA viruses using synthetic genomics assembly tools.

Show Project

Assembly of HSV-1

Use of cutting-edge synthetic genomics technology to revolutionize the study of herpesvirus biology.

Show Project

A Synthetic Human Cytomegalovirus Vaccine Platform

Generation of an HCMV low passage clinical isolate using synthetic genomics.

Show Project

Press Release

J. Craig Venter Institute and UC San Diego Develop Phage Treatment as Potential Cure for Alcoholic Liver Disease

Team targeted specific toxin-producing strains of the bacterium, Enterococcus faecalis, which is shown to be responsible for most liver damage

Collaborator Release

NSF announces new awards for Understanding the Rules of Life

New projects address genetic, environmental causality in biological systems and processes


BioVision Alexandria 2018